Kerin B. Adelson, MD

Articles by Kerin B. Adelson, MD

Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia Inclusion

ByKevin W. Su, MD,Cary P. Gross, MD,Nicholas S. Downing, MD,Kerin B. Adelson, MD,Joseph S. Ross, MD, MHS

July 28th 2017

Evidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.

Latest Updated Articles

Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia Inclusion
Published: July 28th 2017 | Updated:

Kerin B. Adelson, MD

Articles by Kerin B. Adelson, MD

Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia Inclusion

Latest Updated Articles

Trending on Pharmacy Times

A Multifaceted Approach to Navigating Career Transitions in Pharmacy

Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health

Menopause Care Varies by Provider, Highlighting Need for Standardized Education